Neurofeedback and Follow-up With Real-time fMRI to Investigate Cognitive Function in Patients of Mild Cognitive Impairment (MCI) or Alzheimer's Disease (AD)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Alzheimer Dementia (AD)
- Sponsor
- University Hospital, Aachen
- Enrollment
- 30
- Primary Endpoint
- Visual and Verbal Memory Test (VVM)
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The project aims to investigate in patients of Alzheimer's disease in a prodromal state (early state of the disease) compared to healthy subjects whether neurofeedback training with functional MRI (fMRI) can improve cognitive ability. It is of interest if voluntary modulation of brain activation with real-time (rt) fMRI as a novel method affects cognitive ability, as well as functional and structural measures of the brain.
Over the course of the study subjects will learn a real-world footpath. During neurofeedback training subjects are then asked to recall this footpath while simultaneously trying to modulate their own brain activation based on feedback. Feedback is given about the parahippocampal gyrus - a region of the brain associated with episodic and visuo-spatial memory, which is known to be affected early by Alzheimer's disease pathology.
Before and after the training cognitive ability is assessed using neuropsychological tests mainly measuring numerous domains of memory.
The investigators hypothesise that the training leads to an improvement of the trained cognitive domain, but also induces changes in brain structure and function.
Investigators
Kathrin Reetz
Head of Memory Clinic and/or Principal Investigator
University Hospital, Aachen
Eligibility Criteria
Inclusion Criteria
- •Native speakers of German
- •Naive to neurofeedback experiments
- •Ability to provide written informed consent
Exclusion Criteria
- •Metallic implants (MR-safety)
- •Neurological/psychiatric disease (except Alzheimer's disease in the patient group)
- •Use of psychoactive medication (expect medication for Alzheimer's disease)
- •Familiarity with the study site
Outcomes
Primary Outcomes
Visual and Verbal Memory Test (VVM)
Time Frame: 2.5 weeks
Neuropsychological assessment including visuo-spatial memory
Secondary Outcomes
- Wechsler Memory Scale Revised (WMS-R)(2.5 weeks)
- Montreal Cognitive Assessment (MoCA)(2.5 weeks)
- Trail Making Test (TMT)(2.5 weeks)
- Visual Patterns Test (VPT)(2.5 weeks)
- Parahippocampal activation(2.5 weeks)
- Memory-related functional connectivity using Granger Causality Analysis (GCA)(2.5 weeks)
- Change of brain structure(2.5 weeks)
- Change of brain function(2.5 weeks)